Market and Trading Information for Voyager Therapeutics
The following details were available for trading and market data about the stock of Voyager Therapeutics as of writing:
Trading Details of Voyager Therapeutics (VYGR)
Current Share Price:
$8.24
Previous Year's Closing Price:
$8.44
Percentage Price Change (YTD):
-2.37%
Market Cap:
$457.2 million
52-week Price Range:
$6.06 - $14.34
Dividend Per Share:
$0
EPS (TTM):
2.97
Price-Earnings (Trailing):
2.77
Price-Earnings (Forward):
-4.76
Company Profile and Business Description for Voyager Therapeutics
Voyager Therapeutics, Inc., incorporated on June 19, 2013, is a clinical-stage gene therapy company. The Company focuses on developing treatments for patients suffering from severe diseases of the central nervous system (CNS). The Company's pipeline consists of programs for CNS indications, inclu...to see full details, pleaseLogin / Register to view.
ETFs Holding Voyager Therapeutics Stock
As of March 2020, the following exchange-traded funds (ETF) hold the Voyager Therapeutics stocks in their respective portfolios. Below is a random list of only 10 ETFs in no particular order that have Voyager Therapeutics stock holding. There are a total of 27 ETFs in Fknol.com records which are holding Voyager Therapeutics stock in their portfolio. See Full List.
AVUS is an actively managed diverse portfolio of U.S. large-, mid-, and small-cap stocks aiming to find those with lower price relative to valuations. ...Full Details
The Virtus LifeSci Biotech Clinical Trials ETF tracks an equally weighted index of US-listed biotech companies with lead drugs in various phases of clinical trials. ...Full Details
The Goldman Sachs ActiveBeta U.S. Small Cap Equity ETF tracks an index of US small-cap stocks. The index equally weights four factor-based subindexes: value, momentum, quality, and low volatility. ...Full Details
The iShares NASDAQ Biotechnology ETF tracks the performance of a market-cap-weighted index of biotechnology and pharmaceutical companies listed on the NASDAQ. ...Full Details ...Candlestick Patterns.
The iShares Genomics Immunology and Healthcare ETF tracks a market-cap selected and weighted index of global stocks involved in genomics, immunology, and bioengineering. ...Full Details
The iShares Core S&P Total U.S. Stock Market ETF tracks a market cap-weighted index of all common equities listed on the NYSE and the NASDAQ. ...Full Details
The iShares Microcap ETF tracks a market-cap-weighted index of U.S. micro-cap stocks. The index selects the smallest 1000 stocks in the Russell 2000 Index. ...Full Details
See Full List of ETFs holding Voyager Therapeutics stock in their respective portfolios.
U.S. Stock Screener:
Peer / Competitor Companies of Biotech Biological Products Sector
Along with Voyager Therapeutics, Inc., the following other peer (competitor) companies also exist within the same Biotech Biological Products - Healthcare sector whose company profile and dividend history is as follows:
▶ Acceleron Pharma (XLRN): Acceleron Pharma Inc., incorporated on June 13, 2003, is a clinical-stage biopharmaceutical company. The Company is focused on the discovery, development and commercialization of therapeutics to treat serious and rare ....See Detailed Company Profile, Dividend History
▶ Acorda Therapeutics (ACOR): Acorda Therapeutics, Inc., incorporated on March 17, 1995, is a biopharmaceutical company. The Company focuses on developing therapies that restore function and improve the lives of people with neurological disorders. ....See Detailed Company Profile, Dividend History
▶ Adaptimmune Therapeutics (ADAP): Adaptimmune Therapeutics plc, incorporated on December 03, 2014, is a clinical-stage biopharmaceutical company. The Company is focused on cancer immunotherapy products based on its Specific Peptide Enhanced Affinity Receptor (SPEAR) ....See Detailed Company Profile, Dividend History
▶ ADMA Biologics (ADMA): ADMA Biologics, Inc., incorporated on June 2, 2006, is a late-stage biopharmaceutical company that develops, manufactures and intends to market specialty plasma-based biologics for the treatment and prevention of infectious ....See Detailed Company Profile, Dividend History
▶ Adverum Biotechnologies (ADVM): Adverum Biotechnologies, Inc., formerly Avalanche Biotechnologies, Inc., incorporated on July 17, 2006, is a gene therapy company. The Company is engaged in discovering and developing medicines to patients suffering from ....See Detailed Company Profile, Dividend History
▶ Aerie Pharma (AERI): Aerie Pharmaceuticals, Inc., incorporated on June 22, 2005, is a clinical-stage pharmaceutical company. The Company is engaged in the discovery, development and commercialization of therapies for the treatment of patients ....See Detailed Company Profile, Dividend History
▶ Aevi Genomic Medicine (GNMX): Aevi Genomic Medicine, Inc., formerly Medgenics, Inc., incorporated on January 27, 2000, is focused on genomic medicine. The Company is engaged in unlocking the potential of genomic medicine to translate ....See Detailed Company Profile, Dividend History
▶ Agenus (AGEN): Agenus Inc., a clinical-stage immuno-oncology company, focuses on the discovery and development of therapies that engage the body's immune system to fight cancer. The company offers Retrocyte Display,....See Detailed Company Profile, Dividend History
▶ Amgen (AMGN): Amgen Inc., incorporated on October 31, 1986, is a biotechnology company. The Company discovers, develops, manufactures and delivers various human therapeutics. The Company operates in the human therapeutics segment. The ....See Detailed Company Profile, Dividend History
▶ Apollo Endosurgery (APEN): Apollo Endosurgery, Inc., a medical technology company, focuses on the design, development, and commercialization of medical devices. It develops and distributes devices for minimally invasive surgica....See Detailed Company Profile, Dividend History
▶ Applied Genetic (AGTC): Applied Genetic Technologies Corporation, incorporated on October 24, 2003, is a clinical-stage biotechnology company. The Company develops gene therapy products designed to manage the lives of patients with severe diseases ....See Detailed Company Profile, Dividend History
▶ Aptose Biosciences (APTO): Aptose Biosciences Inc. (Aptose), incorporated on November 1, 2006, is a clinical-stage biotechnology company. The Company is engaged in the development of anticancer drugs that target specific epigenetic processes and ....See Detailed Company Profile, Dividend History
▶ Atara Biotherapeutics (ATRA): Atara Biotherapeutics, Inc., incorporated on August 22, 2012, is a clinical-stage biopharmaceutical company. The Company is focused on developing therapies for patients with severe and life-threatening diseases. The Company operates ....See Detailed Company Profile, Dividend History
▶ aTyr Pharma (LIFE): aTyr Pharma, Inc., incorporated on October 8, 2005, is a clinical-stage biotherapeutics company. The Company is engaged in the discovery and clinical development of medicines for patients suffering from severe, ....See Detailed Company Profile, Dividend History
▶ Audentes Therapeutics (BOLD): Audentes Therapeutics, Inc., incorporated on November 13, 2012, is an early-stage biotechnology company. The Company is focused on developing and commercializing gene therapy products for patients suffering from serious, life-threatening ....See Detailed Company Profile, Dividend History
▶ Bavarian Nordic ADR (BVNRY): Bavarian Nordic A S, a biotechnology company, develops, manufactures, and commercializes a portfolio of novel vaccines for the prevention and treatment of life-threatening infectious diseases and cancer. T....See Detailed Company Profile, Dividend History
▶ Bio-Techne (TECH): Bio-Techne Corporation, incorporated on July 17, 1981, develops, manufactures and sells biotechnology reagents and instruments for the research and clinical diagnostic markets. The Company operates through three segments: Biotechnology, Clinical ....See Detailed Company Profile, Dividend History
▶ BioCryst Pharma (BCRX): BioCryst Pharmaceuticals, Inc., incorporated on November 15, 1991, is a biotechnology company. The Company designs, optimizes and develops small molecule drugs that block enzymes involved in the pathogenesis of diseases. ....See Detailed Company Profile, Dividend History
▶ Biogen (BIIB): Biogen Inc., incorporated on April 1, 1997, is a biopharmaceutical company. The Company focuses on discovering, developing, manufacturing and delivering therapies to people living with serious neurological, rare and autoimmune ....See Detailed Company Profile, Dividend History
▶ BiondVax Pharma (BVXV): BiondVax Pharmaceuticals Ltd is an Israel-based biopharmaceutical company. The Company holds a worldwide exclusive license granted by Yeda Research and Development Ltd., the commercial arm of the Weizmann Institute, Israel, ....See Detailed Company Profile, Dividend History